Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Goodwill (2016 - 2025)

Dexcom (DXCM) has disclosed Goodwill for 14 consecutive years, with $24.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Goodwill rose 6.14% to $24.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $24.2 million, a 6.14% increase, with the full-year FY2025 number at $24.2 million, up 6.14% from a year prior.
  • Goodwill was $24.2 million for Q4 2025 at Dexcom, roughly flat from $24.1 million in the prior quarter.
  • In the past five years, Goodwill ranged from a high of $26.6 million in Q1 2022 to a low of $18.9 million in Q1 2021.
  • A 5-year average of $24.1 million and a median of $24.2 million in 2025 define the central range for Goodwill.
  • Peak YoY movement for Goodwill: surged 40.74% in 2022, then decreased 9.73% in 2024.
  • Dexcom's Goodwill stood at $26.5 million in 2021, then fell by 3.02% to $25.7 million in 2022, then dropped by 1.95% to $25.2 million in 2023, then fell by 9.52% to $22.8 million in 2024, then increased by 6.14% to $24.2 million in 2025.
  • Per Business Quant, the three most recent readings for DXCM's Goodwill are $24.2 million (Q4 2025), $24.1 million (Q3 2025), and $24.1 million (Q2 2025).